INTRODUCTION: The aim of this work was to summarize relationships between two subtypes of major depressive disorder (melancholic and atypical) and four core features of depression that reflect the domains identified consistently in previous studies of major depressive disorder endophenotypes (exaggerated reactivity to negative information, altered reward processing, cognitive control deficits, and somatic symptoms) on the one hand and selected peripheral inflammatory markers (C-reactive protein [CRP], cytokines, and adipokines) on the other. METHODS: A systematized review was conducted. The database used for searching articles was PubMed (MEDLINE). RESULTS: According to our search, most peripheral immunological markers associated with major depressive disorder are not specific to a single depressive symptom group. The most evident examples are CRP, IL-6, and TNF-α. The strongest evidence supports the connection of peripheral inflammatory markers with somatic symptoms; weaker evidence indicates a role of immune changes in altered reward processing. The least amount of evidence was found for the role of peripheral inflammatory markers in exaggerated reactivity to negative information and cognitive control deficits. Regarding the depression subtypes, a tendency for higher CRP and adipokines was observed in atypical depression; increased IL-6 was found in melancholic depression. CONCLUSION: Somatic symptoms of depression could be a manifestation of a specific immunological endophenotype of depressive disorder. Melancholic and atypical depression may be characterized by different profiles of immunological markers.

Department of Psychiatry Faculty of Medicine Masaryk University and University Hospital Brno Brno Czechia

Zobrazit více v PubMed

Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, GBD 2015 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct;388((10053)):1545–602. PubMed PMC

Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 2007;68((Suppl 8)):17–25. PubMed

Dooley LN, Kuhlman KR, Robles TF, Eisenberger NI, Craske MG, Bower JE. The role of inflammation in core features of depression: insights from paradigms using exogenously-induced inflammation. Neurosci Biobehav Rev. 2018 Nov;94:219–237. PubMed PMC

Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014 Dec;169:15–20. PubMed

Fried EI, Nesse RM. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord. 2015 Feb;172:96–102. PubMed PMC

Swardfager W, Rosenblat JD, Benlamri M, McIntyre RS. Mapping inflammation onto mood: inflammatory mediators of anhedonia. Neurosci Biobehav Rev. 2016 May;64:148–166. PubMed

Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun. 2002 Feb;16((1)):1–16. PubMed

Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006 Jan;27((1)):24–31. PubMed PMC

Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008 Jan;9((1)):46–56. PubMed PMC

Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009 May;65((9)):732–741. PubMed PMC

Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr;35((3)):664–675. PubMed

Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017 Jan;135((5)):373–387. PubMed

Herkenham M, Kigar SL. Contributions of the adaptive immune system to mood regulation: mechanisms and pathways of neuroimmune interactions. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct;79((Pt A)):49–57. PubMed PMC

Minogue AM. Role of infiltrating monocytes/macrophages in acute and chronic neuroinflammation: effects on cognition, learning and affective behaviour. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct;79((Pt A)):15–18. PubMed

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar;67((5)):446–457. PubMed

Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry. 2020 Jun;25((6)):1301–1311. PubMed PMC

Dey A, Hankey Giblin PA. Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder. Pharmaceuticals. 2018 Jun 25;11((3)):64. PubMed PMC

Haapakoski R, Ebmeier KP, Alenius H, Kivimäki M. Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:63–72. PubMed PMC

Laumet G, Edralin JD, Chiang ACA, Dantzer R, Heijnen CJ, Kavelaars A. Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology. 2018 Jul;43((13)):2597–605. PubMed PMC

Fornaro M, Rocchi G, Escelsior A, Contini P, Martino M. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds. J Affect Disord. 2013 Mar;145((3)):300–307. PubMed

Kast RE. Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels. Gen Hosp Psychiatry. 2003 Nov;25((6)):495–496. PubMed

Baumeister D, Ciufolini S, Mondelli V. Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? Psychopharmacology. 2016;233((9)):1575–1589. PubMed

Halbreich U. Major depression is not a diagnosis, it is a departure point to differential diagnosis-clinical and hormonal considerations (A commentary and elaboration on Antonejevic's paper) Psychoneuroendocrinology. 2006 Jan;31((1)):16–22. author reply 23-4. PubMed

American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: APA; 2013.

World Health Organisation . ICD-10 classifications of mental and behavioural disorder: clinical descriptions and diagnostic guidelines. Geneva: World Health Organisation; 1992.

Juruena MF, Bocharova M, Agustini B, Young AH. Atypical depression and non-atypical depression: is HPA axis function a biomarker? A systematic review. J Affect Disord. 2018 Jun;233:45–67. PubMed

Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004 Jun;29((10)):1765–1781. PubMed

Glahn DC, Curran JE, Winkler AM, Carless MA, Kent JW, Charlesworth JC, et al. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry. 2012 Jan;71((1)):6–14. PubMed PMC

Webb CA, Dillon DG, Pechtel P, Goer FK, Murray L, Huys QJM, et al. Neural correlates of three promising endophenotypes of depression: evidence from the EMBARC study. Neuropsychopharmacology. 2016;41((2)):454–463. PubMed PMC

Raison CL, Miller AH. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D) Mol Psychiatry. 2013;18((1)):15–37. PubMed PMC

National Institute of Mental Health [Internet] RDoC Matrix. [cited 2021 Jul 16]. Available from: https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/constructs/rdocmatrix.shtml.

Sharpley CF, Bitsika V. Differences in neurobiological pathways of four “clinical content” subtypes of depression. Behav Brain Res. 2013 Nov 1;256:368–376. PubMed

Sharpley CF, Bitsika V. Validity, reliability and prevalence of four “clinical content” subtypes of depression. Behav Brain Res. 2014 Feb 1;259:9–15. PubMed

Caroleo M, Carbone EA, Primerano A, Foti D, Brunetti A, Segura-Garcia C. The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: a systematic review. J Affect Disord. 2019 May;250:249–259. PubMed

Rudzki L, Ostrowska L, Pawlak D, Małus A, Pawlak K, Waszkiewicz N, et al. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study. Psychoneuroendocrinology. 2019;100:213–222. PubMed

Yang C, Tiemessen KM, Bosker FJ, Wardenaar KJ, Lie J, Schoevers RA. Interleukin, tumor necrosis factor-α and C-reactive protein profiles in melancholic and non-melancholic depression: a systematic review. J Psychosom Res. 2018 Aug;111:58–68. PubMed

Tiller JWG. Depression and anxiety. Med J Aust. 2012;1((4)):28–31.

Muzina DJ, Kemp DE, McIntyre RS. Differentiating bipolar disorders from major depressive disorders: treatment implications. Ann Clin Psychiatry. 2007 Oct;19((4)):305–312. PubMed

Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol. 2007;2007:076396. PubMed PMC

Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al. Inflammatory markers in major depression and melancholia. J Affect Disord. 2001 Mar;63((1–3)):93–102. PubMed

Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord. 2005 Aug;87((2–3)):305–311. PubMed

Karlović D, Serretti A, Vrkić N, Martinac M, Marčinko D. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res. 2012 Jun;198((1)):74–80. PubMed

Maes M, Mihaylova I, Kubera M, Ringel K. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan;36((1)):169–175. PubMed

Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman ATF, Penninx BWJH. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013;18((6)):692–699. PubMed

Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, et al. Melancholic and atypical major depression − connection between cytokines, psychopathology and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun;43:1–6. PubMed

Glaus J, Vandeleur CL, von Känel R, Lasserre AM, Strippoli MPF, Gholam-Rezaee M, et al. Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study. J Psychiatr Res. 2014 Nov;58:36–45. PubMed

Hickman RJ, Khambaty T, Stewart JC. C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004. J Behav Med. 2014;37((4)):621–629. PubMed

Rudolf S, Greggersen W, Kahl KG, Hüppe M, Schweiger U. Elevated IL-6 levels in patients with atypical depression but not in patients with typical depression. Psychiatry Res. 2014 Jun;217((1–2)):34–38. PubMed

Spanemberg L, Caldieraro MA, Vares EA, Wollenhaupt-Aguiar B, Kauer-Sant'Anna M, Kawamoto SY, et al. Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure. Neuropsychiatr Dis Treat. 2014 Aug;10:1523–1531. PubMed PMC

Yoon HK, Kim YK, Lee HJ, Kwon DY, Kim L. Role of cytokines in atypical depression. Nord J Psychiatry. 2012;66((3)):183–188. PubMed

Lehto SM, Huotari A, Niskanen L, Tolmunen T, Koivumaa-Honkanen H, Honkalampi K, et al. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand. 2010 Mar;121((3)):209–215. PubMed

Milaneschi Y, Lamers F, Bot M, Drent ML, Penninx BWJH. Leptin dysregulation is specifically associated with major depression with atypical features: evidence for a mechanism connecting obesity and depression. Biol Psychiatry. 2017 May;81((9)):807–814. PubMed

Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BWJH. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from The Netherlands Study of Depression and Anxiety (NESDA) Psychoneuroendocrinology. 2013 Sep;38((9)):1573–1585. PubMed

Prossin AR, Koch AE, Campbell PL, McInnis MG, Zalcman SS, Zubieta JK. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry. 2011 Apr;69((8)):808–812. PubMed

Jha MK, Miller AH, Minhajuddin A, Trivedi MH. Association of T and non-T cell cytokines with anhedonia: role of gender differences. Psychoneuroendocrinology. 2018 Sep;95:1–7. PubMed PMC

Tang W, Liu H, Chen L, Zhao K, Zhang Y, Zheng K, et al. Inflammatory cytokines, complement factor H and anhedonia in drug-naïve major depressive disorder. Brain Behav Immun. 2021 Jul;95:238–244. PubMed

Grassi-Oliveira R, Bauer ME, Pezzi JC, Teixeira AL, Brietzke E. Interleukin-6 and verbal memory in recurrent major depressive disorder. Neuro Endocrinol Lett. 2011;32((4)):540–544. PubMed

Pedraz-Petrozzi B, Neumann E, Sammer G. Pro-inflammatory markers and fatigue in patients with depression: a case-control study. Sci Rep. 2020;10((1)):9494. PubMed PMC

Maes M, Twisk FNM, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom. 2012;81((5)):286–295. PubMed

Shi Y, Song R, Wang L, Qi Y, Zhang H, Zhu J, et al. Identifying Plasma Biomarkers with high specificity for major depressive disorder: a multi-level proteomics study. J Affect Disord. 2020 Dec 1;277:620–630. PubMed

Belge JB, Van Diermen L, Sabbe B, Moens J, Morrens M, Coppens V, et al. Improvement of psychomotor retardation after electroconvulsive therapy is related to decreased IL-6 levels. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110146. PubMed

Cho HJ, Savitz J, Dantzer R, Teague TK, Drevets WC, Irwin MR. Sleep disturbance and kynurenine metabolism in depression. J Psychosom Res. 2017 Aug;99:1–7. PubMed PMC

Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory markers and sleep disturbance in major depression. Psychosom Med. 2005 Mar;67((2)):187–194. PubMed

Rethorst CD, Greer TL, Toups MSP, Bernstein I, Carmody TJ, Trivedi MH. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder. Transl Psychiatry. 2015 Aug;5((8)):e611. PubMed PMC

Lamers F, Milaneschi Y, de Jonge P, Giltay EJ, Penninx BWJH. Metabolic and inflammatory markers: associations with individual depressive symptoms. Psychol Med. 2018;48((7)):1102–1110. PubMed

Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, et al. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2020 Jul;25((7)):1457–1468. PubMed PMC

Milaneschi Y, Lamers F, Peyrot WJ, Baune BT, Breen G, Dehghan A, et al. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry. 2017 Dec;74((12)):1214–1225. PubMed PMC

Esel E, Ozsoy S, Tutus A, Sofuoglu S, Kartalci S, Bayram F, et al. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29((4)):565–570. PubMed

Bryleva EY, Keaton SA, Grit J, Madaj Z, Sauro-Nagendra A, Smart L, et al. The acute-phase mediator serum amyloid A is associated with symptoms of depression and fatigue. Acta Psychiatr Scand. 2017 Apr;135((5)):409–418. PubMed

Jain S, Gautam V, Naseem S. Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci. 2011 Jan;3((1)):118–127. PubMed PMC

Lee CH, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. 2019;10:1696. PubMed PMC

Jeon SW, Kim YK. The role of neuroinflammation and neurovascular dysfunction in major depressive disorder. J Inflamm Res. 2018;11:179–192. PubMed PMC

Felger JC. Imaging the role of inflammation in mood and anxiety-related disorders. Curr Neuropharmacol. 2018;16((5)):533–558. PubMed PMC

Jokela M, Virtanen M, Batty GD, Kivimäki M. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016 Jan;73((1)):87–88. PubMed

Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009 May;29((2)):247–264. PubMed PMC

Ge T, Fan J, Yang W, Cui R, Li B. Leptin in depression: a potential therapeutic target. Cell Death Dis. 2018 Oct 26;9((11)):1096. PubMed PMC

Mills PJ, von Känel R, Norman D, Natarajan L, Ziegler MG, Dimsdale JE. Inflammation and sleep in healthy individuals. Sleep. 2007 Jun;30((6)):729–735. PubMed PMC

Center for Disease Control and Prevention [Internet] Symptoms of ME/CFS. [cited 2021 Jul 16]. Available from: https://www.cdc.gov/me-cfs/symptoms-diagnosis/symptoms.html.

Yang T, Yang Y, Wang D, Li C, Qu Y, Guo J, et al. The clinical value of cytokines in chronic fatigue syndrome. J Transl Med. 2019 28;17((1)):213. PubMed PMC

Groven N, Fors EA, Reitan SK. Patients with fibromyalgia and chronic fatigue syndrome show increased hsCRP compared to healthy controls. Brain Behav Immun. 2019;81:172–177. PubMed

Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999 Apr;61((2)):175–180. PubMed

Suarez EC, Sundy JS. The cortisol: C-reactive protein ratio and negative affect reactivity in depressed adults. Health Psychol. 2017 Sep;36((9)):852–862. PubMed PMC

Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002 Mar;7((3)):254–275. PubMed

Glaus J, von Känel R, Lasserre AM, Strippoli MPF, Vandeleur CL, Castelao E, et al. Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study. Psychol Med. 2018;48((6)):961–973. PubMed

Melartin T, Leskelä U, Rytsälä H, Sokero P, Lestelä-Mielonen P, Isometsä E. Co-morbidity and stability of melancholic features in DSM-IV major depressive disorder. Psychol Med. 2004 Nov;34((8)):1443–1452. PubMed

Fagundes CP, Brown RL, Chen MA, Murdock KW, Saucedo L, LeRoy A, et al. Grief, depressive symptoms, and inflammation in the spousally bereaved. Psychoneuroendocrinology. 2019 Feb;100:190–197. PubMed PMC

Brydon L, Walker C, Wawrzyniak AJ, Chart H, Steptoe A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun. 2009 Aug;23((6)):810–816. PubMed PMC

Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016;21((10)):1358–1365. PubMed PMC

Haroon E, Fleischer CC, Felger JC, Chen X, Woolwine BJ, Patel T, et al. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry. 2016 Jan;21((10)):1351–1357. PubMed PMC

Charlton RA, Lamar M, Zhang A, Ren X, Ajilore O, Pandey GN, et al. Associations between pro-inflammatory cytokines, learning, and memory in late-life depression and healthy aging. Int J Geriatr Psychiatry. 2018;33((1)):104–112. PubMed PMC

Chang HH, Lee IH, Gean PW, Lee SY, Chi MH, Yang YK, et al. Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun. 2012 Jan;26((1)):90–95. PubMed

Gallagher D, Kiss A, Lanctot K, Herrmann N. Depressive symptoms and cognitive decline: a longitudinal analysis of potentially modifiable risk factors in community dwelling older adults. J Affect Disord. 2016 Jan;190:235–240. PubMed

Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39((3)):413–423. PubMed PMC

Teunissen CE, van Boxtel MPJ, Bosma H, Bosmans E, Delanghe J, De Bruijn C, et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol. 2003 Jan;134((1–2)):142–150. PubMed

Wright CB, Sacco RL, Rundek TR, Delman JB, Rabbani LE, Elkind MSV. Interleukin-6 is associated with cognitive function: the northern manhattan study. J Stroke Cerebrovasc Dis. 2006 Jan;15((1)):34–38. PubMed PMC

Depp CA, Dev S, Eyler LT. Bipolar depression and cognitive impairment: shared mechanisms and new treatment avenues. Psychiatr Clin North Am. 2016 Mar;39((1)):95–109. PubMed PMC

Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. Toward validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord. 2002 Nov;72((2)):125–138. PubMed

Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D. Atypical depression: a reappraisal. Am J Psychiatry. 2002 Sep;159((9)):1470–1479. PubMed

Posternak MA, Zimmerman M. Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry. 2002 Jan;59((1)):70–76. PubMed

Angst J, Gamma A, Benazzi F, Silverstein B, Ajdacic-Gross V, Eich D, et al. Atypical depressive syndromes in varying definitions. Eur Arch Psychiatry Clin Neurosci. 2006;256((1)):44–54. PubMed

Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI. Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology. 2015;40((7)):1709–1716. PubMed PMC

Qu N, Zhang SF, Xia B, Xie JZ, Wang XM, Liu J, et al. Sex difference in IL-6 modulation of cognition among Chinese individuals with major depressive disorder. J Clin Neurosci. 2019 Dec;70:14–19. PubMed

Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder